PIII icon

P3 Health Partners

8.99 USD
+0.24
2.74%
At close Apr 30, 4:00 PM EDT
1 day
2.74%
5 days
0.78%
1 month
9.50%
3 months
2.74%
6 months
-52.05%
Year to date
-28.08%
1 year
-66.53%
5 years
-98.14%
10 years
-98.14%
 

About: P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Employees: 360

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

7.41% less ownership

Funds ownership: 19.83% [Q3] → 12.42% (-7.41%) [Q4]

15% less funds holding

Funds holding: 46 [Q3] → 39 (-7) [Q4]

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

63% less capital invested

Capital invested by funds: $12.4M [Q3] → $4.57M (-$7.81M) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$20
122%
upside
Avg. target
$20
122%
upside
High target
$20
122%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Lake Street
Brooks O'Neil
50% 1-year accuracy
8 / 16 met price target
122%upside
$20
Buy
Maintained
21 Apr 2025

Financial journalist opinion

Positive
Zacks Investment Research
2 weeks ago
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
P3 Health Partners (PIII) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
Neutral
Business Wire
4 weeks ago
P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will give a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3's in.
P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference
Neutral
Seeking Alpha
1 month ago
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Ryan Halsted - IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Medical Officer Conference Call Participants Josh Raskin - Nephron Research David Larsen - BTIG Ryan Langston - TD Cowen Jack Senft - William Blair Operator Good day and welcome to the P3 Health Partners' Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript
Negative
Zacks Investment Research
1 month ago
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago.
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
Neutral
Business Wire
1 month ago
P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. “Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention,” said Aric Coffman, CEO of P3. “With the $130M+.
P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results
Neutral
Business Wire
1 month ago
P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Cal.
P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27
Positive
Zacks Investment Research
1 month ago
P3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
P3 Health Partners (PIII) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
P3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Neutral
Business Wire
2 months ago
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts. Management is scheduled to host investor meetings on Wednesday March 5th, 2025. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transfor.
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference
Neutral
Business Wire
2 months ago
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered, physician-led population health management company, is targeting profitability in 2025, with initial revenue guidance for the year of $1.350 billion to $1.500 billion and Adjusted EBITDA of negative ($35) million to $5 million. “The execution of our previously announced $130+ million EBITDA growth initiatives is going as planned, most of which have been actioned and implemented.
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
Neutral
GlobeNewsWire
2 months ago
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
Charts implemented using Lightweight Charts™